Company news
Si-bone, Inc. (NASDAQ:SIBN) news
Si-bone, Inc. news releases on 6ix. Latest, Jan 30, 2024: SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant…
Press releases — page 2
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
January 29, 2024
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
January 7, 2024
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
November 13, 2023
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
November 5, 2023
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
October 31, 2023
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
October 15, 2023
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods
September 4, 2023
SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
August 28, 2023
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance
August 6, 2023
SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023
July 18, 2023
SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023
July 16, 2023
SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023
May 23, 2023
SI-BONE Announces Pricing of Public Offering of Common Stock
May 3, 2023
SI-BONE Announces Launch of Public Offering of Common Stock
May 3, 2023
SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance
April 30, 2023
SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference
April 23, 2023
SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023
April 9, 2023
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance
February 26, 2023
SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023
February 5, 2023
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022
January 8, 2023
SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth Conference
January 2, 2023
SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant System
December 26, 2022
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates Guidance
November 6, 2022
SI-BONE To Report Third Quarter 2022 Financial Results on November 7, 2022
October 16, 2022
SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference
August 22, 2022
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022
August 7, 2022
SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022
July 17, 2022
SI-BONE To Present at The Canaccord Genuity 42nd Annual Growth Conference 2022
July 17, 2022
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
June 12, 2022
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology
May 30, 2022
SI-BONE, Inc. Reports First Quarter 2022 Financial Results
May 8, 2022
SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment
April 18, 2022
SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022
April 17, 2022
SI-BONE To Present at BofA Securities 2022 Healthcare Conference
April 17, 2022
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance
February 27, 2022
SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
January 31, 2022
SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021
January 9, 2022
SI-BONE to participate in 24th Annual Needham Virtual Growth Conference
December 26, 2021
Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors
December 13, 2021
SI-BONE, Inc. Announces Updated Exclusive Blue Cross Blue Shield Association Evidence Street Opinion, and New Coverage Policies from Arkansas Blue Cross Blue Shield and Walmart Plans from BlueAdvantage Administrators of Arkansas
December 12, 2021
SI-BONE, Inc. Reports Third Quarter 2021 Financial Results and Updates 2021 Financial Guidance
November 7, 2021
SI-BONE To Report Third Quarter 2021 Financial Results on November 8, 2021
October 17, 2021
SI-BONE, Inc. Announces UnitedHealthcare Adopts Exclusive iFuse Only Coverage for Minimally Invasive SI Joint Fusion
October 10, 2021
SI-BONE to Participate in Upcoming Conferences
August 22, 2021
SI-BONE, Inc. Reports Second Quarter 2021 Financial Results and Announces Exclusive Coverage from Anthem
August 1, 2021
SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangular iFuse Implant System® for Its More Than 40 Million Members
August 1, 2021
SI-BONE to Present at the Canaccord Genuity 41st Annual Growth Conference
July 28, 2021
SI-BONE To Report Second Quarter 2021 Financial Results on August 2, 2021
July 19, 2021
SI-BONE, Inc. Announces Centene Establishes Positive Coverage for MIS SI Joint Fusion including the Triangular iFuse Implant System
July 13, 2021
SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use
July 6, 2021